blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1278544

EP1278544 - ALBUMIN FUSION PROTEINS [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  29.04.2011
Database last updated on 20.05.2024
Most recent event   Tooltip29.04.2011Refusal of applicationpublished on 01.06.2011  [2011/22]
Applicant(s)For all designated states
Human Genome Sciences, Inc.
14200 Shady Grove Road
Rockville, MD 20850 / US
[2011/14]
Former [2003/05]For all designated states
HUMAN GENOME SCIENCES, INC.
9410 Key West Avenue
Rockville, MD 20850-3338 / US
Inventor(s)01 / ROSEN, Craig, A.
22400 Rolling Hill Lane
Laytonsville, MD 20882 / US
02 / HASELTINE, William, A.
3035 P. Street, N.W.
Washington, DC 20007 / US
 [2003/05]
Representative(s)Bassett, Richard Simon, et al
Potter Clarkson LLP The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
[N/P]
Former [2003/05]Bassett, Richard Simon, et al
Eric Potter Clarkson, Park View House, 58 The Ropewalk
Nottingham NG1 5DD / GB
Application number, filing date01941457.212.04.2001
[2003/05]
WO2001US12013
Priority number, dateUS20000229358P12.04.2000         Original published format: US 229358 P
US20000199384P25.04.2000         Original published format: US 199384 P
US20000256931P21.12.2000         Original published format: US 256931 P
[2003/05]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0179444
Date:25.10.2001
Language:EN
[2001/43]
Type: A2 Application without search report 
No.:EP1278544
Date:29.01.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 25.10.2001 takes the place of the publication of the European patent application.
[2003/05]
Search report(s)International search report - published on:US23.05.2002
(Supplementary) European search report - dispatched on:EP06.07.2004
ClassificationIPC:A61K39/395, A61K47/48, C07K1/00, C07K14/56, C07K14/62, C07K14/705, C07K14/76, C07K14/61, C07K14/65, C07K14/715, C07K14/765
[2004/34]
CPC:
A61K38/4846 (EP,US); A61K38/21 (EP,US); A61K38/212 (EP,US);
A61K38/38 (EP,US); A61K47/65 (US); A61K9/0019 (EP,US);
A61P1/00 (EP); A61P1/04 (EP); A61P1/16 (EP);
A61P1/18 (EP); A61P11/00 (EP); A61P11/06 (EP);
A61P13/00 (EP); A61P13/02 (EP); A61P13/08 (EP);
A61P13/12 (EP); A61P15/00 (EP); A61P15/08 (EP);
A61P15/10 (EP); A61P15/18 (EP); A61P17/00 (EP);
A61P17/02 (EP); A61P17/06 (EP); A61P17/12 (EP);
A61P17/14 (EP); A61P19/00 (EP); A61P19/02 (EP);
A61P19/08 (EP); A61P19/10 (EP); A61P21/00 (EP);
A61P21/04 (EP); A61P25/00 (EP); A61P25/02 (EP);
A61P25/08 (EP); A61P25/16 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P3/10 (EP);
A61P3/14 (EP); A61P31/00 (EP); A61P31/12 (EP);
A61P31/14 (EP); A61P31/16 (EP); A61P31/18 (EP);
A61P31/20 (EP); A61P31/22 (EP); A61P33/02 (EP);
A61P33/06 (EP); A61P33/12 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P35/04 (EP); A61P37/00 (EP);
A61P37/02 (EP); A61P37/04 (EP); A61P37/06 (EP);
A61P37/08 (EP); A61P39/02 (EP); A61P41/00 (EP);
A61P43/00 (EP); A61P5/00 (EP); A61P5/10 (EP);
A61P5/14 (EP); A61P5/40 (EP); A61P7/00 (EP);
A61P7/04 (EP); A61P7/06 (EP); A61P9/00 (EP);
A61P9/06 (EP); A61P9/10 (EP); A61P9/12 (EP);
C07K14/56 (EP,US); C07K14/61 (EP,US); C07K14/62 (EP,US);
C07K14/65 (EP,US); C07K14/705 (EP,US); C07K14/7151 (EP,US);
C07K14/76 (EP,US); C07K14/765 (EP,US); C12N15/62 (EP,US);
C12N9/96 (EP,US); A01K2217/05 (EP,US); A61K2039/54 (EP,US);
A61K47/42 (EP,US); A61K48/00 (EP,US); C07K2319/00 (EP,US);
C07K2319/21 (EP,US); C07K2319/31 (EP,US); C07K2319/50 (EP,US);
C07K2319/75 (EP,US); Y02A50/30 (EP,US) (-)
Former IPC [2003/05]A61K39/395, A61K39/00, A61K38/00, C07K1/00
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/05]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ALBUMIN FUSIONSPROTEINE[2003/05]
English:ALBUMIN FUSION PROTEINS[2003/05]
French:PROTEINES HYBRIDES D'ALBUMINE[2003/05]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase18.10.2002National basic fee paid 
18.10.2002Search fee paid 
18.10.2002Designation fee(s) paid 
18.10.2002Examination fee paid 
Examination procedure08.11.2001Request for preliminary examination filed
International Preliminary Examining Authority: US
18.10.2002Examination requested  [2003/05]
25.10.2004Despatch of a communication from the examining division (Time limit: M06)
15.06.2005Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
15.08.2005Reply to a communication from the examining division
06.03.2006Despatch of a communication from the examining division (Time limit: M06)
07.09.2006Reply to a communication from the examining division
20.09.2007Cancellation of oral proceeding that was planned for 16.10.2007
20.09.2007Minutes of oral proceedings despatched
15.10.2007Despatch of communication that the application is refused, reason: substantive examination [2011/22]
16.10.2007Date of oral proceedings (cancelled)
28.03.2011Application refused, date of legal effect [2011/22]
Appeal following examination30.11.2007Appeal received No.  T0410/08
08.02.2008Statement of grounds filed
28.03.2011Result of appeal procedure: appeal of the applicant withdrawn
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.10.2004
Request for further processing for:15.08.2005Request for further processing filed
15.08.2005Full payment received (date of receipt of payment)
Request granted
06.09.2005Decision despatched
Fees paidRenewal fee
22.04.2003Renewal fee patent year 03
26.04.2004Renewal fee patent year 04
20.04.2005Renewal fee patent year 05
26.04.2006Renewal fee patent year 06
27.04.2007Renewal fee patent year 07
25.04.2008Renewal fee patent year 08
29.04.2009Renewal fee patent year 09
26.04.2010Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9315199  (RHONE POULENC RORER SA [FR]) [X] 1-36 * the whole document *;
 [X]WO9315211  (RHONE POULENC RORER SA [FR]) [X] 1-36 * the whole document *;
 [X]WO9618412  (BETH ISRAEL HOSPITAL [US]) [X] 1-36 * the whole document *;
 [X]WO9724445  (DELTA BIOTECHNOLOGY LTD [GB], et al) [X] 1-36 * the whole document *;
 [X]  - YEH P ET AL, "Design of yeast-secreted albumin derivatives for human therapy: biological and antiviral properties of a serum albumin -CD4 genetic conjugate", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, (19920301), vol. 89, no. 5, ISSN 0027-8424, pages 1904 - 1908, XP002130704 [X] 1-36 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.89.5.1904
International search[Y]WO9013653  (DELTA BIOTECHNOLOGY LTD [GB]);
 [Y]US5948428  (LEE JOHN C [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.